- Home » News and EventsPage 29
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Smart Drug Development and Design to be Discussed at Symposium
Jan 29, 2019
SOMERSET, N.J. – January 29, 2019 — The Catalent Applied Drug Delivery Institute today announced that it is to hold a one-day symposium entitled “Smart Drug Development and Design” on Wednesday, Feb. …
Debate on Patient-Focused Biologic Design to be Led by Catalent at DDP
Jan 24, 2019
Debate on Patient-Focused Biologic Design to be Led by Catalent at DDP. SOMERSET, N.J. – January 24, 2019 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and…
Assay Automation to be Presented at WCBP Symposium
Jan 17, 2019
Assay Automation to be Presented at WCBP Symposium. SOMERSET, N.J. – January 17, 2019 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutio…
Catalent Invests $200 Million to Expand Biologics Capacity and Capabilities
Jan 7, 2019
(NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has commenced a $200 million…
Catalent Celebrates 20 Years at Philadelphia Facility
Dec 6, 2018
SOMERSET, N.J. – December 6, 2018 — Catalent Pharma Solutions, the leading pharmaceutical development company, recently celebrated 20 years of operations at its North America Center of Excellence for …
Catalent Invests to Expand Biologics Packaging Capabilities at Bloomington
Dec 3, 2018
Catalent Invests to Expand Biologics Packaging Capabilities at Bloomington. SOMERSET, N.J. – December 3, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies…
Biohaven Delivers Positive Phase 3 Results with Rimegepant
Dec 3, 2018
Catalent welcomes Biohaven’s announcement that it has Delivered Positive Phase 3 Results with Rimegepant Zydis® Orally Dissolving Tablet (ODT): Rapid and Lasting Benefit for the Acute Treatment of Mig…
Catalent Expands Clinical Packaging Capabilities in Shanghai, China
Nov 27, 2018
Catalent Expands Clinical Packaging Capabilities in Shanghai, China. SOMERSET, N.J. – November 27, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and d…
Biohaven announces FDA acceptance of 505(b)(2) NDA filing for BHV-0223
Nov 26, 2018
Catalent welcomes the announcement by its partner, Biohaven, of the FDA’s Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic…
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.